IBCSG 23-01 randomised controlled trial comparing axillary dissection versus no axillary dissection in patients with sentinel node micrometastases

BACKGROUND: For breast cancer patients with a metastatic sentinel node (SN), axillary dissection (AD) has been standard treatment. However, for patients with minimal SN involvement, AD may be overtreatment. IBCSG Trial 23-01 was designed to determine whether no AD is non-inferior to AD in patients w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Galimberti, Viviana, Cole, Bernard F., Zurrida, Stefano, Viale, Giuseppe, Luini, Alberto, Veronesi, Paolo, Baratella, Paola, Chifu, Camelia, Sargenti, Manuela, Intra, Mattia, Gentilini, Oreste, Mastropasqua, Mauro G., Mazzarol, Giovanni, Massarut, Samuele, Garbay, Jean-Remi, Zgajnar, Janez, Galatius, Hanne, Recalcati, Angelo, Littlejohn, David, Bamert, Monika, Colleoni, Marco, Price, Karen N., Regan, Meredith M., Goldhirsch, Aron, Coates, Alan S., Gelber, Richard D., Veronesi, Umberto
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3935346/
https://ncbi.nlm.nih.gov/pubmed/23491275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(13)70035-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items